David Hsiehchen, John H. Lohrey, Radhika Kainthla, Syed Mohammad Ali Kazmi, Nilesh Verma, Carrie Manwaring, Chul Ahn, Hao Zhu. "Domvanalimab plus zimberelimab in unresectable and immunotherapy refractory biliary tract cancers: a phase 2 trial." Nature Communications, 2026. doi:10.1038/s41467-026-75554-z